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arp loci are variable in multiple samples from the
same patient
Lenka Mikalová1, Petra Pospíšilová1, Vladana Woznicová2, Ivana Kuklová3, Hana Zákoucká4 and David Šmajs1*Abstract
Background: Molecular typing of syphilis-causing strains provides important epidemiologic data. We tested
whether identified molecular subtypes were identical in PCR-positive parallel samples taken from the same patient
at a same time. We also tested whether subtype prevalence differs in skin and blood samples.
Results: Eighteen syphilis positive patients (showing both positive serology and PCR), with two PCR-typeable
parallel samples taken at the same time, were tested with both CDC (Centers for Disease Control and Prevention)
and sequence-based typing. Samples taken from 9 of 18 patients were completely typed for TP0136, TP0548, 23S
rDNA, arp, and tpr loci. The CDC typing revealed 11 distinct genotypes while the sequence-based typing identified
6 genotypes. When results from molecular typing of TP0136, TP0548, and 23S rDNA were analyzed in samples taken
from the same patient, no discrepancies in the identified genotypes were found; however, there were discrepancies
in 11 of 18 patients (61.1%) samples relative to the arp and tpr loci. In addition to the above described typing, 127
PCR-positive swabs and whole blood samples were tested for individual genotype frequencies. The repetition
number for the arp gene was lower in whole blood (WB) samples compared to swab samples. Similarly, the most
common tpr RFLP type “d” was found to have lower occurrence rates in WB samples while type “e” had an
increased occurrence in these samples.
Conclusions: Differences in the CDC subtypes identified in parallel samples indicated genetic instability of the arp
and tpr loci and suggested limited applicability of the CDC typing system in epidemiological studies. Differences in
treponemal genotypes detected in whole blood and swab samples suggested important differences between both
compartments and/or differences in adherence of treponeme variants to human cells.
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Syphilis, caused by Treponema pallidum ssp. pallidum
(T. pallidum), is a sexually transmitted multistage disease
with a diagnosis based on clinical symptoms, serological
findings and other methods such as direct detection of
treponemes by microscopy. In the 1990s, PCR-based
methods for direct detection of treponemal DNA were
developed [1]. Since then, several improvements in these* Correspondence: dsmajs@med.muni.cz
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reproduction in any medium, provided the ortests have been published which have increased sensitivity
and specificity [2-9] as well as the ability to detect the
presence of several pathogens simultaneously in the same
reaction using multiplex PCR [10,11]. A major advantage
of PCR–based methods in syphilis diagnostics is the
potential for subsequent molecular typing of syphilis trep-
onemes. Although several treponemal genomic loci were
tested relative to their suitability for molecular typing
[12-14], most molecular typing studies of treponemal
DNA are performed using CDC typing [15]. The method
involves detection of the number of 60-bp tandem repeats
in the arp (acidic repeat protein) gene and restrictional Ltd. This is an Open Access article distributed under the terms of the Creative
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PCR-amplified tpr genes (tprE, G, J). In 2010, the CDC
method was modified by addition of sequencing of
TP0548 [14] or by determination of the number of G
repeats within the rpsA gene (TP0279) [16].
Recently, a sequencing-based molecular typing scheme
based on sequencing of the TP0136, TP0548 and 23S
rRNA genes was introduced [17]. Moreover, the sequence
variants of TP0136, TP0548 and 23S rRNA genes have
been shown to independently combine with variants of
the arp and tpr genes [17].
In this communication, we compare CDC typing with
sequence-based molecular typing in a group of patients
with two or more parallel samples (i.e. taken at the same
time) that were PCR-positive for treponemal DNA.
Moreover, the variability of gene sequences, length and
RFLP genotypes are compared in two types of clinical
specimens (i.e. swab and whole blood samples).
Results
PCR detection and molecular typing of syphilis
treponemes
A total of 18 patients had two PCR-typeable samples
(taken at the same time), which were used for amplifica-
tion of treponemal TP0136, TP0548, 23S rRNA genes,
tpr and arp loci. Two separate PCR-typeable swabs were
available for each of 9 patients in one group of patients,
while a second group of 9 patients had a single PCR-
typeable swab along with a whole blood sample. Four
patients were diagnosed with secondary syphilis while
the remaining 14 patients had primary syphilis (Table 1).
The samples from these 18 patients were typed with
both CDC and sequence-based typing schemes [15,17],
the results are shown in Table 1. Samples taken from 9 of
18 patients were completely typed at all loci (TP0136,
TP0548, 23S rDNA, arp, and tpr). The remaining 9 patient
samples were partially typed (10 samples were partially
typed at the TP0136, TP0548, and 23S rDNA loci and 4
samples were partially typed at the arp and tpr loci). CDC
typing revealed 11 distinct genotypes while sequence-
based typing revealed 6 genotypes. The identified se-
quences of TP0136, TP0548 and 23S rDNA loci are shown
in Additional file 1. Using enhanced CDC typing [14], 13
different genotypes were found (Table 1). When results of
molecular typing of TP0136, TP0548, and 23S rDNA were
available, no discrepancies in the genotypes were identified
in samples taken from the same patients (Table 1). In
contrast, samples taken from 11 of 18 patients (61.1%)
revealed discrepancies at the arp and tpr loci (1 for arp, 9
for tpr and 1 for both of these loci). The most frequent
discrepancies involved the “d” and “e” (4 cases), “d” and
“b” (2 cases) and “d” and “p” (2 cases) patterns of the tpr
genes. Two of four patients with secondary syphilis had
differences at the tpr loci (Table 1).When analysis of loci used in sequence-based (i.e. ana-
lysis of TP0136, TP0548 and 23S rDNA) and CDC typing
(i.e. arp and tpr genes) was performed independently, 14
swab/blood paired DNA samples were analyzed in both
sequence-based typing and in CDC typing. While no
discrepancies were found in sequence-based typing, 8 out
of 14 genotypes detected in CDC typing were different.
Similarly, analysis of parallel swabs revealed 26 and 18
typed DNA samples for sequence-based and CDC typing,
respectively. No discrepancies were found in sequence-
based typing while 4 out of 18 genotypes detected in CDC
typing were different.
Four of 9 (44.4%) patients (with two positive swabs for
treponemal DNA) showed differences in tpr gene patterns
while 7 of 9 (77.8%) patients (with swabs and whole blood
samples) showed pattern differences at the arp or tpr loci.
The 2 differences found in the arp gene were found in pa-
tients with both swab and whole blood samples and in
both cases the repetitions number of the arp gene was
lower in whole blood samples compared to swab samples.
Variability of treponemal genotypes found in whole
blood and swab samples
To test whether individual genotype rates differ in swabs
vs. whole blood samples, the occurrence rates of individual
genotypes was determined in swabs and whole blood sam-
ples (Table 2) using the data set from Flasarová et al. [17]
augmented by samples collected in 2011 in the Czech
Republic. Altogether, 93 swabs and 34 whole blood sam-
ples were analyzed. Among the investigated strains, similar
proportions of sequences (i.e. SS14-like and unique) were
identified for loci TP0136 and TP0548. Similarly, both
A2058G and A2059G mutations in the 23S rDNA showed
similar occurrence rates in swabs and whole blood sam-
ples (Table 2). However, the number of repetitions in the
arp gene showed a significant difference between swab
and WB samples. The arp gene with a lower number of
repetitions was found to occur more often in WB samples.
In addition, the most common tpr RFLP type “d” occurred
less often in WB samples while type “e” had a higher
occurrence rate in WB samples.
Discussion
Molecular detection of treponemal DNA and the subse-
quent molecular typing of T. pallidum strains have
allowed epidemiological mapping of treponemal syphilis
strains [15]. In recent years, there has been increasing evi-
dence showing differences in molecular genetic markers
among virulent treponemal strains isolated in different
countries [14,16-34]. Some studies have shown that pre-
dominant treponemal strains in a particular population
can change over time [14,17].
The selection of suitable genetic loci appears to be of
enormous importance. Genetic loci suitable for molecular
Table 1 Molecular typing of treponemal DNA isolated from a set of 16 patients with two or more samples positive for
treponemal DNA
Patient no. Syphilis stage Sample Material Genotypes based on TP0136,
TP0548, 23S rDNA
CDC subtype Enhanced CDC subtype*
1 Primary 43K StI Swab SSS 14d 14d/f
44K StII Swab SSS 14d 14d/f
2 Primary 36K St Swab SU2R8 14d 14d/g
37K Whole blood SU2R8 12d 12d/g
3 Primary 93K Swab SXS 14k 14k/X
94K Whole blood XSX 14e 14e/f
4 Primary 891 Swab SSS 14d 14d/f
892 Swab SSS 14p 14p/f
5 Primary 91K Swab SSR8 14d 14d/f
92K Whole blood SXX 12e 12e/X
6 Primary C-150 Swab U1SS 8b 8b/f
D-151 Swab U1SS 8d 8d/f
7 Primary 8032 Swab SSR9 15d 15d/f
8284 Swab SSR9 15d 15d/f
8 Primary 19512 Swab SU2R8 14d 14d/g
19527 Swab SU2R8 14b 14b/g
9 Primary 15K St Swab SSS 14d 14d/f
16K Whole blood XSS XXe XXe/f
10 Primary RL104BZ Swab SU2R8 14d 14d/g
RL104AZ Whole blood XU2R8 14X 14X/g
11 Primary 63K Swab SSR9 15d 15d/f
62K Whole blood XSR9 15d 15d/f
12 Primary 4K Swab SSS 14d 14d/f
5K Swab SSS 14d 14d/f
13 Primary 34K St Swab SSS 14d 14d/f
35K Whole blood XXS XXe XXe/X
14 Primary RL116A Swab SU2R8 14e 14e/g
RL116B Whole blood SXR8 14j 14j/X
15 Secondary 15577 Swab SXS 14d 14d/X
15578 Swab SSS 14d 14d/f
16 Secondary G-269 Swab SU1S 14p 14p/f
H-270 Swab SU1S 14d 14d/f
17 Secondary 51K Swab SSS 14d 14d/f
52K Swab SSS 14d 14d/f
18 Secondary 73K Swab SU2R8 14d 14d/g
74K Whole blood XXR8 XXe XXe/X
X, the exact genotype was not determined.
*subtype identification based on CDC typing enhanced by sequence analysis of TP0548 between position 131–215 [14].
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and relatively high stability in future generations of the
microbial population. Several genetic loci including tprK,
tprC and the intergenic region between TP0126-TP0127
have been tested for their suitability for molecular typingand rejected because of multiallelic sequences [12] or
because of a lack of discriminatory power [14].
The most widely used molecular typing system [15]
and its improved versions [14,16] are in principle based
on detection of genetic variability in the arp and tpr
Table 2 Genotypes identified in PCR positive swabs and whole blood samples
Genes Type of sample Statistical significance
Locus nucleotide sequences Swabs (n = 93) WB samples (n = 34)
TP0136 Identical to strain SS14 96.1% (74/77) 100.0% (12/12)
Unique sequences 3.9% (3/77) 0.0% (0/12)
TP0548 Identical to strain SS14 74.4% (58/78) 68.8% (11/16)
Unique sequences 25.6% (20/78) 31.3% (5/16)
23S rDNA wt 60.4% (55/91) 51.6% (16/31)
A2058G 28.6% (26/91) 25.8% (8/31)
A2059G 11.0% (10/91) 22.6% (7/31)
Number of repetitions in the arp locus
Swabs WB samples
arp 14 82.4% (56/68) 55.6% (5/9) p = 0.03
15 11.8% (8/68) 11.1% (1/9)
8-12 5.9% (4/68) 33.3% (3/9) p = 0.003
tpr E, G, J tpr E, G, J pattern after MseI digest
Swabs WB samples
d 91.2% (62/68) 30.8% (4/13) p < 0.001
e 1.5% (1/68) 46.2% (6/13) p < 0.001
b, p, k, j 7.4% (5/68) 23.1% (3/13)
Samples isolated in the work of Flasarová et al. [17] augmented by samples collected in 2011 in the Czech Republic were analyzed. Results show both paired and
unpaired samples.
wt, wildtype.
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the arp gene code for highly immunogenic protein se-
quences and represent a potential fibronectin-binding
domain. The arp gene in T. pallidum strains is subject
to positive selection and the size variation in repeat mo-
tifs in T. pallidum strains is likely connected with mech-
anisms that treponemes use to escape/evade the host’s
immune response, which has been primed against the
standard (and the most prevalent repeat number among
clinical samples) 14-repeat variant [36]. Genes tprE, G
and J are potential virulence factors and belong to tpr
subfamily II [37]. These genes are expressed during
syphilis infection [38,39] and the TprEJ proteins are
likely located on the outer membrane [40,41]. Recently,
Giacani et al. [40] demonstrated how the number of
poly-G repeats effected transcription of tprE, G, and J
through a phase variation mechanism, and the modulat-
ing effect of the TP0262 gene on the level of transcrip-
tion of these tpr genes [42]. We have shown that these
loci are often variable in samples taken from the same
patient. Although coinfection with two genetically differ-
ent treponemal strains cannot be excluded, it appears
unlikely since typing with other markers, including the
TP0136, TP0548, and 23S rDNA loci, revealed identical
sequences despite the fact that the latter typing scheme
identified only 6 different genotypes among the 18
patients sampled in this study.Under experimental conditions, Pillay et al. [15] showed
that the CDC genotype is stable in repeated rabbit pas-
sages of T. pallidum Nichols strain and others have
confirmed this finding [14]. Moreover, genetic stability
has been shown for two additional treponemal strains
(Sea 81–4 and Chicago C) using experimental infections
of rabbits [14]. However, human infection may differ
considerably from experimental rabbit infections. These
differences represent differences in IL-2 levels produced
by Th1 cells (Helper T cells) during the early cellular
response to T. pallidum in the rabbit model, where the
mRNA IL-2 levels were considerably lower than IL-10
levels [43]. On the other hand, IL-2 mRNA levels in
early human lesions had comparable levels of IL-10
[44]. Moreover, in contrast to rabbit infections, CD8+
T-cells are often the dominant T-cell during human
infections [45].
It has been shown that skin and blood represent two
immunologically distinct compartments with respect to
syphilis infections [45]. Cellular immunity seems to be
more important than humoral immunity in the clearance
of T. pallidum from early syphilis lesions [46]. The inabil-
ity of humoral immunity to control the infection is dem-
onstrated by formation of secondary syphilis lesions
despite the presence of high antibody titers against trepo-
nemal antigens [44]. It is likely that these immunologically
different compartments produce different selection forces
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blood. To confirm this hypothesis, we tested a spectrum
of different genotypes from both swabs and whole blood
samples. Interestingly, the spectrum of the arp and tpr
variant significantly differed between swabs and whole
blood samples indicating their instability and differences
in selection of treponeme variants in both niches. Alterna-
tively, differences in the arp and tpr loci could result in
lowered adherence of these treponemes to human cells
prompting increased migration of these treponemes from
primary lesions to other human compartments.
There are only a few studies describing the genetic ana-
lysis of multiple parallel samples taken from one patient at
the same time [24,34]. Moreover, only a limited number of
parallel samples were analyzed in these studies (i.e. involv-
ing 2–4 patients) and this fact likely precluded identifica-
tion of the variability of detected genotypes. In addition,
only a limited number of studies used whole blood samples
for molecular typing, mainly because of lower frequency of
PCR-positive results [18,47-49]. When the published data
were analyzed [15,16,18-20,22,24-26,29-32], 19 WB and
536 swab samples were fully typed using the CDC typing
system. The most prevalent subtype in swab samples was
14d (351 samples, 65.5%), which were similar to our
results (14d subtypes in 50 out of 68 fully typed swabs,
73.5%). As with swabs, the 14 repetition version of the arp
gene was also the most common in WB samples. The
most common tpr profile in WB samples was ‘a’, found in
17 of 19 WB samples [18,22]. Interestingly, none of the
WB subtypes identified in our study (12d, 12e, 14e, 14j,
14k, 15d) were similar to the published WB subtypes.
There are several limitations to this study. One of these
is the small number of available parallel PCR-typeable
samples taken from the same patient. Therefore, observed
differences should be interpreted with caution and more
parallel samples need to be tested in future. Another limi-
tation is the small number of fully-typed samples, espe-
cially in the sequence-based typing system. The observed
lower discriminatory power of sequence-based typing
compared to CDC typing is likely a result of genetic vari-
ability of tpr and arp loci, however, this explanation needs
to be verified.
Taken together, parallel samples taken from the same
patient, at the same time, revealed potential instability
at the tpr and arp loci, which is often used in molecular
typing of treponemes. These loci are likely to show
treponemal intra-strain variability and the results of
molecular typing should be interpreted with caution,
especially in epidemiological studies. Differences in
frequencies of genotypes in whole blood and swab
samples suggest an antigenic/adherence character for
proteins encoded by these loci and also immunological
differences between compartments (i.e. skin and whole
blood).Conclusions
The CDC typing scheme revealed subtype differences in
parallel samples taken from 11 of 18 tested patients
(61.1%). The arp and tpr loci are likely to show trepo-
nemal intra-strain variability since the sequence-based
typing system revealed identical sequences in the TP0136,
TP0548, and 23S rRNA genes. Therefore, the results of
CDC typing should be interpreted with caution, especially
in epidemiological studies. Differences in treponemal
genotypes detected in whole blood and swab samples
suggest immunological differences between the skin and
whole blood compartments and/or differences in adher-
ence of genetic variants of treponemes to human cells.Methods
Collection of clinical samples
Clinical samples were collected from 2006 – 2012 in
several clinical departments in the Czech Republic
(Department of Medical Microbiology and Department of
Dermatology, Faculty of Medicine, St. Anne’s Hospital and
Masaryk University Brno, Department of Dermatology,
Faculty Hospital Brno, Department of Dermatology, 1st
Faculty of Medicine, Charles University in Prague, the
National Reference Laboratory for Diagnostics of Syphilis,
and the National Institute for Public Health, Prague).
All clinical samples were collected after patients gave in-
formed consent. Syphilis was diagnosed based on clinical
symptoms and results of several serological tests (e.g. Rapid
Plasma Reagin (RPR) test, Venereal Disease Research
Laboratory (VDRL) test, T. pallidum Hemagglutination
Assay (TPHA), T. pallidum Particle Agglutination Assay
(TPPA), ELISA IgM and IgG tests and Western blot ana-
lyses of IgM and IgG levels). The study was approved by
the ethics committee of the Faculty of Medicine, Masaryk
University, Czech Republic.
Two types of clinical samples were used for PCR testing,
swabs and whole blood samples. Skin and mucosal swabs
were transported to the laboratory in a dry state in a ster-
ile capped tube with no fluid transport medium. Whole
blood samples (3 ml) were drawn into commercially avail-
able containers supplemented with 5.4 mg of K2EDTA.
Samples collected from Prague’s departments were stored
at −20°C and transported on dry ice to the laboratory for
PCR testing on bimonthly basis. DNA was extracted
within 24 hours after transportation of these samples.
Samples from hospitals in Brno underwent DNA extrac-
tion within 1–5 days after collection.
Several patients provided two parallel samples, which
were obtained during the same physician visit. A com-
bination of two swabs, taken from different sites of the
same lesion or from two separate lesions, or a swab and
a whole blood sample were obtained from syphilis sero-
positive patients.
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Treponemal DNA was isolated as described previously
[17] from swabs, which were submerged in 1.5 ml of
sterile water and agitated for 5 min at room temperature
(0.2 – 0.4 ml of the liquid phase was used for isolation),
and from whole blood (0.2 – 0.8 ml) using a QIAamp
DNA Mini kit (Qiagen, Hilden, Germany) and the Blood
and Body Fluid Spin Protocol. DNA was eluted to 60 μl
with AE buffer.
For detection of treponemal DNA in clinical samples,
a nested PCR amplification of polA (TP0105) and tmpC
(TP0319) genes was performed as described previously
[5,13,17,50].Molecular typing of treponemal DNA and DNA
sequencing
Treponemal loci (TP0136, TP0548 and 23S rRNA genes)
were amplified using nested PCR protocols according to
Flasarová et al. [17]. Briefly, each PCR reaction contained
0.5 μl of 10 mM dNTP mix, 2.5 μl of 10× ThermoPol Re-
action buffer, 0.25 μl of each primer (100 pmol/μl), 0.05 μl
of Taq polymerase (5000 U/ml, New England BioLabs,
Frankfurt am Main, Germany), 1 or 10 μl of sample and
variable amounts of PCR grade water in 25 μl reactions.
PCR amplification was performed at the following cycling
conditions: 94°C (1 min); 94°C (30 s), 48°C (30 s), 72°C
(60 s), 30 cycles; 72°C (7 min) for TP0136, TP0548 and
23S rRNA genes. The second step of nested PCR was
performed under the same conditions, but with an in-
creased number of cycles (40 cycles).
PCR products were visualized with 1.5% agarose gels,
purified using a QIAquick PCR Purification Kit (Qiagen,
Hilden, Germany) and sequencing was completed using a
Taq DyeDeoxy Terminator Cycle Sequencing Kit (Applied
Biosystems, Foster City, CA, USA). Sequence alignments
and assemblies were carried out using the LASERGENE
program package (DNASTAR, Madison, USA). For deter-
mination of mutations at position 2058 [51,52] and 2059
[53] in the 23S rRNA gene, a MboII/BsaI restriction digest
assay was used [53]. The number of 60-bp repetitions in
the arp gene was determined as described previously
[14,15] and amplification of the tprE, G, and J genes, using
nested PCR, was done according to Pillay et al. [15] with
two modifications described in Flasarová et al. [17]. The
RFLP analysis was carried out according to Pillay et al.
[15]. DNA isolated from T. pallidum strain Nichols
(Houston) was used as a control for CDC (arp/tprEGJ)
and sequence-based genotyping (TP0136/TP0548/23S
rRNA).Statistical methods
Standard methods derived from the binomial distribution,
including two-tailed tests were used. An interactivecalculation tool for chi-square tests of “goodness of fit”
and independence was used [54].
Availability of supporting data
All sequences identified by sequence-based typing of
TP0136, TP0548 and 23S rDNA loci are described in an
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